Stockreport

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House [Yahoo! Finance]

Champions Oncology, Inc.  (CSBR) 
NASDAQ:AMEX Investor Relations: championsoncology.com/investors
PDF a license to use radioactive materials in preclinical studies. This approval allows in-house work utilizing a variety of clinically relevant radionuclides, significantly [Read more]